Financial and Investment Analysts H-1B salary at Horizon Therapeutics USA, Inc.: $132,193 average ($132,193-$132,193 range). 100% approval rate.
Horizon Therapeutics USA, Inc. has filed 2 H-1B petitions for the Financial and Investment Analysts role, offering an average compensation of $132k. The average offered salary of $132k is 8% above the prevailing wage for this occupation. Most positions are located in Illinois (100%). The certification rate is 100%.
| Total Filings | 2 |
| Approval Rate | 100% |
| Average Salary | $132,193 |
| Median Salary | $132,193 |
| 25th Percentile | $132,193 |
| 75th Percentile | $132,193 |
| Minimum Salary | $132,193 |
| Maximum Salary | $132,193 |
100% of filings offer salaries above the prevailing wage, with an average premium of 7.7%. The average prevailing wage is $123k (based on 2 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 7 days. Based on 2 filings.
0% of filings are for new positions, while 0% are for continued employment (2 filings with data).
Average contract duration: 36 months (median: 36 months), based on 2 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 2 |
| State | Filings |
|---|---|
| Illinois | 2 |
Horizon Therapeutics USA, Inc. has 2 H-1B filings for Financial and Investment Analysts positions in our database of DOL public records.
The average H-1B salary for Financial and Investment Analysts at Horizon Therapeutics USA, Inc. is $132,193, with a median of $132,193. Salaries range from $132,193 to $132,193.
The H-1B approval rate for Financial and Investment Analysts positions at Horizon Therapeutics USA, Inc. is 100% based on 2 DOL filings.
See how Financial and Investment Analysts salaries compare across different H-1B sponsors.